Advertisement

Hepatic Drug-Metabolizing Enzymes during Embryonic and Fetal Development

  • Allan B. Okey
  • Daniėl Nebert
Part of the Hepatology book series (H, volume 5)

Abstract

Twenty or thirty years ago, it was believed that all drugs (and other environmental pollutants) were “toxic”, or pharmacologically active, in their parent (non-metabolized) form. The function of all drug-metabolizing enzymes was therefore regarded as detoxication, i.e. to “inactivate” the active parent drug. More recently it has become increasingly evident that although some drugs are, indeed, active in their nonmetabolized parent form, many drugs are inactive until being metabolized (1,2). A delicate balance exists, therefore, between detoxication and toxification.

Keywords

Sister Chromatid Exchange Slow Acetylators Monooxygenase Activity Polycyclic Hydrocarbon Polycyclic Aromatic Compound 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    GOLDSTEINA,ARONOWL,KALMANSM (eds):Principles of Drug Action, 2nd Edition, John Wiley & Sons, N.Y. 1974. 854 pages.Google Scholar
  2. 2.
    MILLERJA,MILLEREC: Perspectives on the metabolism of chemical carcinogens. InEnvironmental Carcinogenesis: Occurrence,Risk Evaluation and Mechanism. Netherlands Cancer Society, Amsterdam, Netherlands. 1979. pp. 25–50.Google Scholar
  3. 3.
    OMURAT,SATOR: The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature.J Biol Chem 239: 2370–2378, 1964.PubMedGoogle Scholar
  4. 4.
    SATOR,OMURAT (eds):Cytochrome P-450. Academic Press, N.Y. 1978. 233 pages.Google Scholar
  5. 5.
    NEBERTDW: Multiple forms of inducible drug-metabolizing enzymes. A reasonable mechanism by which any organism can cope with adversity.Mol Cell Biochem 27: 27–46, 1979.PubMedCrossRefGoogle Scholar
  6. 6.
    MASONHS,FOWLKSWL,PETERSONE: Oxygen transfer and electron transport by the phenolase complex.J Amer Chem Soc 77: 2914–2915, 1955.CrossRefGoogle Scholar
  7. 7.
    HAYAISHIO,KATAGIRIM,ROTHBERGS: Mechanism of the pyro-catechase reaction.J Amer Chem Soc 77: 5450–5451, 1955.CrossRefGoogle Scholar
  8. 8.
    SUGIURAM,YAMAZOEY,KAMATAKIT,KATOR: Reduction of epoxy derivatives of benzo(a)pyrene by microsomal cytochrome P-450.Cancer Res 40: 2910–2914, 1980.PubMedGoogle Scholar
  9. 9.
    YAMAZOEY,ISHIIK,YAMAGUCHIN,KAMATAKIT,KATOR: Reduction of N-hydroxy-2-acetylaminofluorene by liver microsomes.Bochem Pharmacol 29: 2183–2188, 1980.CrossRefGoogle Scholar
  10. 10.
    FREYWA,VALLEEBL: Digitalis metabolism and human liver alcohol dehydrogenase.Proc Nat Acad Sci USA 77: 924–927, 1980.PubMedCrossRefGoogle Scholar
  11. 11.
    PATELJM,WOODJC,LEIBMANKC: The biotransformation of al.lyl alcohol and acrolein in rat liver and lung preparations.Drug Metab Disp 8: 305–308, 1980.Google Scholar
  12. 12.
    PATELJ,HARPERC,DREWRT: The biotransformation of p-xylene to a toxic aldehyde.Drug Metab Disp 6: 368–374, 1978.Google Scholar
  13. 13.
    LINDC,VADIH,ERNSTERL: Metabolism of benzo(a)pyrene-3,6-quinone and 3-hydroxybenzo(a)pyrene in liver microsomes from 3-methylcholanthrene-treated rats. A possible role of DT-diaphorase in the formation of glucuronyl conjugates.Arch Biochem Biophys 190: 97–108, 1978.PubMedCrossRefGoogle Scholar
  14. 14.
    CHENGELISCP,NEALRA: Studies of carbonyl sulfide toxicity: Metabolism by carbonic anhydrase.Toxicol Appl Pharmacol55: 198–202, 1980.PubMedCrossRefGoogle Scholar
  15. 15.
    DUTTONGJ,WISHARTG,CAMPBELLMT: Perinatal development of glucuronidation. InAdvances in Pharmacology and Thera peutics: Drug-action Modification, Comparative Pharmacology,volume 8. E. Oliver (ed.) Pergamon Press, Ltd., Oxford, England. 1978. pp. 113–122.Google Scholar
  16. 16.
    JAKOBYWB: The glutathione S-transferases: a group of multifunctional detoxification proteins. InAdvances in Enzymology and Related Areas of Molecular Biology. A. Meister (ed). John Wiley & Sons, Inc., N.Y. 1978. pp. 383–414.Google Scholar
  17. 17.
    OESCHF: Epoxide hydratase. InProgress in Drug Metabolism, volume 3. J.W. Bridges, L.F. Chasseaud (eds). John Wiley & Sons, N.Y. 1979. pp. 253–301.Google Scholar
  18. 18.
    SHUMS,JENSENNM,NEBERTDW: The Ah locus:In uterotoxicity and teratogenesis associated with genetic differences in benzo(a)pyrene metabolism.Teratology 20:365–376, 1979.PubMedCrossRefGoogle Scholar
  19. 19.
    KINOSHITAN,GELBOINHV: (3-Glucuronidase catalyzed hydrolysis of benzo(a)pyrene-3-glucuronide and binding to DNA.Science 199: 307–309, 1978.PubMedCrossRefGoogle Scholar
  20. 20.
    TAMURAG,GOLDC,FERRO-LUZZIA,AMESBN: Fecalase: a model for activation of dietary glycosides to mutagens by intestinal flora.Proc Nat Acad Sci USA 77: 4961–4965, 1980.PubMedCrossRefGoogle Scholar
  21. 21.
    EVANSDAP,WHITETA: Human acetylation polymorphism.J Lab Clin Med 63: 394–403, 1964.PubMedGoogle Scholar
  22. 22.
    CRIGLERJF,NAJJARVA: Congenital familial non-hemolytic jaundice with kernicterus.Pediatrics 10: 169–180, 1952.PubMedGoogle Scholar
  23. 23.
    SOLOMONHM: Variations in metabolism of coumarin anticoagulant drugs.Ann NY Acad Sci 151: 932–935, 1968.PubMedGoogle Scholar
  24. 24.
    SHIHVE,ABROMSIF,JOHNSONJL,CARNEYM,MANDELLR,ROBBRM,CLOHERTYJP,RAJAGOPALANKV: Sulfite oxidase deficiency. Biochemical and clinical investigations of a hereditary metabolic disorder in sulfur metabolism.N Eng J Med 297: 1022–1028, 1977.CrossRefGoogle Scholar
  25. 25.
    WEISSCF,GLAZKOAJ,WESTONJK: Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses.N Eng J Med 262:787–794, 1960.CrossRefGoogle Scholar
  26. 26.
    KLINGERW: Development of drug metabolizing enzymes. InDrug Disposition During Development. P.L. Morselli (ed). Spectrum Publications, Inc., N.Y. 1977. pp. 71–88.Google Scholar
  27. 27.
    ARANDAJV,SITARDS,PARSONSWD,LOUGHNANPM,NEIMSAH: Pharmacokinetic aspects of theophylline in premature newborns.N Eng J Med 295: 413–416, 1976.CrossRefGoogle Scholar
  28. 28.
    KALOWW,BRITTBA,RICHTERA: The caffeine test of isolated human muscle in relation to malignant hyperthermia.Can Anaesth Soc J 24: 678–694, 1977.PubMedCrossRefGoogle Scholar
  29. 29.
    SOMAYAJIBN,PATONA,PRICEJH,HARRISAW,FLEWETTTH: Nor-ethìsterone jaundice in two sisters.Brit Med J 2: 281–283, 1968.PubMedCrossRefGoogle Scholar
  30. 30.
    MULLENPW: Immunopharmacological considerations in Reye’s syndrome: A possible xenobiotic initiated disorder?Biochem Pharmacol 27: 145–149, 1978.PubMedCrossRefGoogle Scholar
  31. 31.
    O’REILLYRA: The second reported kindred with hereditary resistance to oral anticoagulant drugs.N Eng J Med 282: 1448–1451, 1970.CrossRefGoogle Scholar
  32. 32.
    BROWNMS,GOLDSTEINJL: Receptor-mediated endocytosis: Insights from the lipoprotein receptor system.Proc Nat Acad Sci USA 76: 3330–3337, 1979.PubMedCrossRefGoogle Scholar
  33. 33.
    MCINTYREOR,SULLIVANLW,JEFFRIESGH,SILVERRH: Pernicious anemia in childhood.N Eng J Med 272: 981–986, 1965.CrossRefGoogle Scholar
  34. 34.
    MARVERHS,SCHMIDR: The porphyrias. InThe Metabolic Basis of Inherited Disease: J.B. Stanbury, J.B. Wyngaarden, D.S. Frederickson (eds). McGraw-Hill. N.Y. 1972. pp. 1087–1140.Google Scholar
  35. 35.
    WANGYM, VANEYSJ: The enzymatic defect in essential pentos-uria.N Eng M Med 282:892–896, 1970.CrossRefGoogle Scholar
  36. 36.
    DELUCAHF: Vitamin D metabolism and function. InMonographs on Endocrinology. F. Gross, A. Labhart, T. Mann, J. Zander (eds). Springer-Verlag, Berlin & N.Y. 1979. pp. 1–78.Google Scholar
  37. 37.
    BOSSGR,SEEGMILLERJE: Hyperuricemia and gout. Classification, complications and management.N Eng J Med 300: 1459–1468, 1979.CrossRefGoogle Scholar
  38. 38.
    LEEPA,PLOTNICKLP,KOWARSKIAA,MIGEONCJ: InCongenital Adrenal Hyperplasia. University Park Press, Baltimore, Md. 1977.Google Scholar
  39. 39.
    BROWNBR,SIPESIG: Biotransformation and hepatotoxicity of halothane.Biochem Pharmacol 26: 2091–2094, 1977.PubMedCrossRefGoogle Scholar
  40. 40.
    YUNISAA: Chloramphenicol-induced bone marrow suppression.Sem Hematol 10: 225–234, 1973.Google Scholar
  41. 41.
    MITCHELLJR,JOLLOWDJ: Biochemical basis for drug-induced hepatotoxicity.Isr J Med Sci 10:312–318, 1974.Google Scholar
  42. 42.
    BOIVINP,GALANDC,BERNARDJF: Deficiencies in GSH biosynthesis. InGlutathione. L. Flohe, H.C. Benöhr, H. Sies, H.D. Waller, A. Wendel (eds). Academic Press, N.Y. 1974. pp. 146–157.Google Scholar
  43. 43.
    SPIELBERGSP,GARRICKMD,CORASHLM,BUTLERJD,TIETZEF,ROGERSLV,SCHULMANJD: Biochemical heterogeneity in glutathione synthetase deficiency.J Clin Invest 61: 1417–1420, 1978.PubMedCrossRefGoogle Scholar
  44. 44.
    LÖHRGW,BLUMEKG,RÜDIGERHW,ARNOLDH: Genetic variability in the enzymatic reduction of oxidized glutathione. InGlutathione. L. Flohe, H.C. Benöhr, H. Sies, H.D. Waller, A. Waller, A. Wendel (eds). Academic Press, N.Y. 1974. pp. 165–173.Google Scholar
  45. 45.
    NECHELESTF: The clinical spectrum of glutathione-peroxidase deficiency. InGlutathione. F. Flohe, H.C. Benöhr, H. Sies, H.D. Waller, A. Wendel (eds). Academic Press, N.Y. 1974. pp. 173–180.Google Scholar
  46. 46.
    BEUTLER, E: Disorders due to enzyme defects in the red blood cell.Adv Metab Disord 6: 131–160, 1972.Google Scholar
  47. 47.
    SCOTTEM: The relation of diaphorase of human erythrocytes to inheritance of methemoglobinemia.J Clin Invest 39: 1176–1179, 1960.PubMedCrossRefGoogle Scholar
  48. 48.
    HUEHNSER,SHOOTEREM: Human haemoglobins.J Med Genet 2: 48–90, 1965.PubMedCrossRefGoogle Scholar
  49. 49.
    COMINGSDE: Hemoglobinopathies producing cyanosis. InHematology. W.J. Williams, E. Beutler, A.J. Erslev, R.W. Rundles (eds). McGraw-Hill, N.Y. 1972. pp. 434–440.Google Scholar
  50. 50.
    SHAHIDIHT: Acetophenetidin-induced methemoglobinemia.Ann NY Acad Sci 151: 822–832, 1968.PubMedGoogle Scholar
  51. 51.
    NEBERTDW: The Ah locus. A gene with possible importance in cancer predictability.Arch Toxicol Suppl . 3: 195–207, 1980.PubMedCrossRefGoogle Scholar
  52. 52.
    NEBERTDW: Human genetic variation in the enzymes of detoxica-tion. InEnzymatic Basis of Detoxication, volume 1. W.B. Jakoby (ed). Academic Press, N.Y. 1980. pp. 25–68.Google Scholar
  53. 53.
    MAURERHM,WOLFFJA,FINSTERM,POPPERSPJ,PANTUCKE,KUNTZMANR,CONNEYAH: Reduction in concentration of total serum bil.irubin in offspring of women treated with phenobarbitone during pregnancy.Lancet ii: 122–124, 1968.CrossRefGoogle Scholar
  54. 54.
    LIGGINSGC: Premature delivery of foetal lambs infused with glucocorticosteroids.J Endocrinol 45: 515–522, 1969.PubMedCrossRefGoogle Scholar
  55. 55.
    HERBSTAL,ULFELDERH,POSKANZERDC: Adenocarcinoma of the vagina association of maternal stilbestrol therapy with tumor appearance in young women.N Eng J Med 284: 878–881, 1971.CrossRefGoogle Scholar
  56. 56.
    GREENWALDP,BARLOWJJ,NASCAPC,BURNETTWS: Vaginal cancer after maternal treatment with synthetic estrogens.N Eng J Med 285: 390–393, 1971.CrossRefGoogle Scholar
  57. 57.
    DONEAK: Developmental pharmacology.Clin Pharmacol Ther 5: 432–479, 1964.PubMedGoogle Scholar
  58. 58.
    SERENIF,MANDELLIM,PRINCIPIN,TOGNONIG,PARDIG,MORSELLIPL: Induction of drug metabolizing enzyme activities in the human fetus and in the newborn infant.Enzyme 15: 318–329, 1973.PubMedGoogle Scholar
  59. 59.
    YAFFESJ,JUCHAUMR: Perinatal pharmacology.Ann Rev Pharmacol14: 219–238, 1974.CrossRefGoogle Scholar
  60. 60.
    GILLETTEJR,STRIPPB: Pre-and postnatal capacity for drug metabolite production.Fed Proc 34: 172–178, 1975.PubMedGoogle Scholar
  61. 61.
    MIRKINBL (ed):Perinatal Pharmacology and Therapeutics. Academic Press, N.Y. 1976.Google Scholar
  62. 62.
    NEIMSAH,WARNERM,LOUGHNANPM,ARANDAJV: Developmentalaspects of the hepatic cytochrome P450 monooxygenase system.Ann Rev Pharmacol 16: 427–445, 1976.CrossRefGoogle Scholar
  63. 63.
    PELKONENO: Transplacental transfer of foreign compounds and their metabolism by the foetus. InProgress in Drug Metab olism, volume 2. J.W. Bridges, L.F. Chasseaud (eds). John Wiley & Sons, London. 1977. pp 119–161.Google Scholar
  64. 64.
    HUNTERJ,CHASSEAUDLF: Clinical aspects of microsomal enzyme induction. InProgress in Drug Metabolism, volume 1.J.W. Bridges, L.F. Chasseaud (eds). John Wiley & Sons, London. 1977. pp. 129–191.Google Scholar
  65. 65.
    NEUBERTD,BARRACHH-J: Special aspects of pre-and perinatal toxicology and pharmacology. InAdvances in Pharmacology and Therapeutics: Drug-action Modification, Comparative Pharmacology, volume 8. E. Oliver (ed). Pergamon Press Ltd, Oxford, England. 1978. pp. 71–79.Google Scholar
  66. 66.
    PELKONENO,KARKINT,KORHONENP,KOIVISTOM,TUIMALAR,KAUPPILAA: Indueibility of monooxygenase activities in the human fetus and placenta. InAdvances in Pharmacology and Therapeutics: Drug-action Modification, Comparative Pharmacology, volume 8. E. Oliver (ed). Pergamon Press Ltd., Oxford, England. 1978. pp. 101–122Google Scholar
  67. 67.
    HUGHESHB,BIEHLJP,JONESAP,SCHMIDTLH: Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis.Am Rev Tuberc 70: 266–273, 1954.PubMedGoogle Scholar
  68. 68.
    REIDENBERGMM,DRAYERDE,ROBBINWC: Polymorphic drug acetylation and systemic lupus erythematosus. InAdvances in Pharmacology and Therapeutics: Clinical Pharmacology,volume 6. P. Duchene-Marullaz (ed). Pergamon Press, Oxford, England. 1979. pp. 51–56.Google Scholar
  69. 69.
    CUMMINSLH,KOZAKPP Jr,GILLMANSA: Theophylline determinations.Ann Allergy 37: 450–451, 1976.PubMedGoogle Scholar
  70. 70.
    CONNEYAH: Pharmacological implications of microsomal enzyme induction.Pharmacol Rev 19: 317–366, 1967.PubMedGoogle Scholar
  71. 71.
    NEBERTDW,EISENHJ,NEGISHIM,LANGMA,HJELMELANDLM,OKEYAB: Genetic mechanisms controlling the induction of polysubstrate monooxygenase (P-450) activities.Ann Rev Pharmacol Toxicol: in press, 1981.Google Scholar
  72. 72.
    PELKONENO,JOUPPILAP,KÄRKINT: Effect of maternal cigarette smoking on 3,4-benzpyrene and N-methylaniline metabolism in human fetal liver and placenta.Toxicol Appl Pharmacol23: 399–407, 1972.PubMedCrossRefGoogle Scholar
  73. 73.
    CONNEYAH,LEVINW,JACOBSONM,KUNTZMANR: Specificity in the regulation of the 6ß-, 7-and 16-hydroxylation of testosterone by rat liver microsomes. InMicrosomes and Drug Oxidations. J.R. Gillette, A.H. Conney, G.J. Cosmides, R.W. Estabrook, J.R. Fouts, G.J. Mannering (eds). Academic Press, N.Y. 1969. pp. 279–302.Google Scholar
  74. 74.
    MANCHESTERDK,NEIMSAH: The effect of birth on the maturation of hepatic cytochrome(s) P-450 mono-oxygenase and tyrosine aminotransferase activities in the guinea pig.Biol Neonate31: 213–218, 1977.PubMedCrossRefGoogle Scholar
  75. 75.
    NEBERTDW: Genetic differences in susceptibility to chemically induced myelotoxicity and leukemia.Env Health Perspect:in press, 1980.Google Scholar
  76. 76.
    POLANDAP,GLOVERE,ROBINSONJR,NEBERTDW: Genetic expression of aryl hydrocarbon hydroxylase activity. Induction of monooxygenase activities and cytochrome P1–450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically “nonresponsive” to other aromatic hydrocarbons.J Biol Chem 249: 5599–5606, 1974.PubMedGoogle Scholar
  77. 77.
    NEBERTDW,JENSENNM: The Ah locus: Genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases. InCRC Critical Reviews in Biochemistry, volume 6. G.D. Fasman (ed). CRC Press, Inc., Cleveland, Ohio. 1979. pp. 401–437.Google Scholar
  78. 78.
    POLANDAP,GLOVERE,KENDEAS: Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is the receptor for the induction of aryl hydrocarbon hydroxylase.J Biol Chem 253.:4936–4946, 1976.Google Scholar
  79. 79.
    OKEYAB,BONDYGP,MASONME,KAHLGF,EISENHJ,GUENTHNERTM,NEBERTDW: Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation.J Biol Chem 254:11636–11648, 1979.PubMedGoogle Scholar
  80. 80.
    OKEYAB,BONDYGP,MASONME,NEBERTDW,FORSTER-GIBSONCJ,MUNCANJ,DUFRESNEMJ: Temperature-dependent cytosol-to nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines.J Biol Chem: in press, 1980.Google Scholar
  81. 81.
    POLANDA,GLOVERE: Chlorinated dibenzo-p-dioxins: Potent inducers of -aminolevulinic acid synthetase and aryl hydrocarbon hydroxylase. II. A study of the structure activity relationship.Mol Pharmacol 9: 736–747, 1973.PubMedGoogle Scholar
  82. 82.
    NEBERTDW,CONSIDINEN,OWENSIS: Genetic expression of aryl hydrocarbon hydroxylase induction. VI. Control of other aromatic hydrocarbon-indueible mono-oxygenase activities at or near the same genetic locus.Arch Biochem Biophys148–159, 1973.Google Scholar
  83. 83.
    LANGMA,NEBERTDW: Structural gene products of the Ah complex. Evidence for multiple forms of liver microsomal cytochrome P-450 from 3-methylcholanthrene-treated mice.J Biol Chem: in press, 1981.Google Scholar
  84. 84.
    NEBERTDW,JENSENNM,PERRYJW,OKAT: Association between ornithine decarboxylase induction and the Ah locus in mice treated with polycyclic aromatic compounds.J Biol Chem 255: 6836–6842, 1980.PubMedGoogle Scholar
  85. 85.
    NEBERTDW,GOUJONFM,GIELENJE: Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: Simple autosomal dominant trait in the mouse.Nature New Biol (London) 236: 107–110, 1972.Google Scholar
  86. 86.
    ATLASSA,BOOBISAR,FELTONJS,THORGEIRSSONSS,NEBERTDW: Ontogenetic expression of polycyclic aromatic compound indueible monooxygenase activities and forms of cytochrome P-450 in the rabbit. Evidence for temporal control and organ specificity of two genetic regulatory sytems.J Biol Chem 252:4712–4721, 1977.PubMedGoogle Scholar
  87. 87.
    GUENTHNERTM,NEBERTDW: Evidence in rat and mouse liver for temporal control of two forms of cytochrome P-450 inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin.Eur J Biochem 91: 449–456, 1978.PubMedCrossRefGoogle Scholar
  88. 88.
    NEGISHIM,NEBERTDW: Structural gene products of the Ah locus. Genetic and immunochemical evidence for two forms of mouse liver cytochrome P-450 induced by 3-methylcholanthrene.J Biol Chem 254; 11015–11023, 1979.PubMedGoogle Scholar
  89. 89.
    KAHLGF,FRIEDERICID,BIGELOWSW,OKEYAB,NEBERTDW: Ontogenetic expression of regulatory and structural gene products associated with the Ah locus. Comparison of rat, mouse, rabbit, andSigmoden hispedis.Devel Pharmacol Ther 1: 137–162, 1980.Google Scholar
  90. 90.
    SMITHDW (ed):Recognizable Patterns of Human Malformation. W.B. Saunders Company, Philadelphia, Pa. 1976. 504 pages.Google Scholar
  91. 91.
    NEBERTDW,LEVITTRC,JENSENNM,LAMBERTGH,FELTONJS: Birth defects and aplastic anemia: Differences in polycyclic hydrocarbon toxicity associated with the Ah locus.Arch Toxicol 39: 109–132, 1977.PubMedCrossRefGoogle Scholar
  92. 92.
    NEBERTDW: Etiology of birth defects. Potential importance of genetic differences in drug metabolism. InDeterminants of Drug Metabolism in the Immature Human. Raven Press, N.Y. 1981. In press.Google Scholar
  93. 93.
    LATTSA,ALLENJW,STETTENG: Invitroand invivoanalyses of chromosome structure, replication, and repair using BrdU-33258 Hoechst techniques. InProceedings of the First International Congress on Cell Biology. B.R. Brinkley, K.R. Porter (eds). Rockefeller University Press, N.Y. 1977. pp. 520–527.Google Scholar
  94. 94.
    WOLFFS: Sister chromatid exchange.Ann Rev Genet 11: 183–201, 1977.PubMedCrossRefGoogle Scholar
  95. 95.
    GALLOWAYSM,PERRYPE,MENESESJ,NEBERTDW,PEDERSENRA: Cultured mouse embryos metabolize benzo(a)pyrene during early gestation: Genetic differences detectable by sister chromatid exchange.Proc Nat Acad Sci USA 77: 3524–3528, 1980.PubMedCrossRefGoogle Scholar
  96. 96.
    KELLERMANNG,SHAWCR,LUYTEN-KELLERMANNM: Aryl hydrocarbon hydroxylase indueibility and bronchogenic carcinoma.N Eng J Med 289: 934–937, 1973.CrossRefGoogle Scholar
  97. 97.
    PAIGENB,WARDE,STEENLANDK,HOUTENL,GURTOOHL,MINOWADAJ: Aryl hydrocarbon hydroxylase in cultured lymphocytes of twins.Am J Hum Genet 30: 561–571, 1978.PubMedGoogle Scholar
  98. 98.
    TRELLE,KORSGAARDR,HOODB,KITZINGP,NORDENG,SIMONSSONBG: Aryl hydrocarbon hydroxylase indueibility and laryngeal carcinomas.Lancet 2: 140, 1976.PubMedCrossRefGoogle Scholar
  99. 99.
    TRELLE,KORSGAARDR: Smoking and oral carcinoma.Lancet 1: 671, 1978.Google Scholar
  100. 100.
    TRELLE,OLDBRINGJ,KORSGAARDR,MATTIASSONI: Aryl hydrocarbon hydroxylase indueibility in carcinoma of renal pelvis and ureter.Lancet 2: 612, 1977.PubMedCrossRefGoogle Scholar
  101. 101.
    TRELLE,OLDBRINGJ,KORSGAARDR,HELLSTENS,MATTIASSONI,TELHAMMARE: Aryl hydrocarbon hydroxylase inducibility and carcinoma of the urinary bladder.IRCS J Med Sci 6: 138, 1978.Google Scholar
  102. 102.
    BLUMERJL,DUNNR,GROSSS: Lymphocyte aryl hydrocarbon hydroxylase (AHH) inducibility in acute leukemia of childhood (AL).Proc Am Assoc Cancer Res 20: 310, 1979.Google Scholar
  103. 103.
    LUBELLDL: Fatal hepatic necrosis associated with zoxazolamine therapy.NY State J Med 62: 3807–3810, 1962.Google Scholar
  104. 104.
    JICKH,PORTERJ,MORRISONAS: Relation between smoking and age of natural menopause.Lancet 1: 1354–1355, 1977.PubMedCrossRefGoogle Scholar
  105. 105.
    VESSEYMP,WRIGHTNH,MCPHERSONK,WIGGINSP: Fertility after stopping different methods of contraception.Brit Med J 1: 265–267, 1978.PubMedCrossRefGoogle Scholar
  106. 106.
    COHENSB,BURKRF: Acetaminophen overdoses at a county hospital: A year’s experience.So Med J 71: 1359–1364, 1978.CrossRefGoogle Scholar
  107. 107.
    NEBERTDW: The Ah locus: Genetic differences in toxic response to foreign compounds. InMicrosomes, Drug Oxidations, and Chemical Carcinogenesis, volume II. M.J. Coon, A.H. Conney, Ä.W. Estabrook, H.V. Gelboin, J.R. Gillette, P.J. O’Brien (eds). Academic Press, M.Y. 1980. pp. 801–812.Google Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Allan B. Okey
    • 1
    • 2
  • Daniėl Nebert
    • 1
    • 2
  1. 1.Division of Clinical Pharmacology, Dept. PaediatricsThe Hospital for Sick ChildrenTorontoCanada
  2. 2.Developmental Pharmacology BranchNational Institute of Child Health and Human Development, National Institutes of HealthBethesdaUSA

Personalised recommendations